Victory Capital Management Inc Vir Biotechnology, Inc. Transaction History

Victory Capital Management Inc

$99 Billion
Q3 2024

A detailed history of Victory Capital Management Inc transactions in Vir Biotechnology, Inc. stock. As of the latest transaction made, Victory Capital Management Inc holds 81,269 shares of VIR stock, worth $702,164. This represents 0.0% of its overall portfolio holdings.

Number of Shares

81,269

Previous 65,573 23.94%

Holding current value

$702,164

Previous $583,000 4.29%

% of portfolio

0.0%

Previous 0.0%

21 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 05, 2024	BUY	$7.26 - $10.7 $113,952 - $167,947	15,696 Added 23.94%	81,269 $608,000
Q2 2024 Aug 05, 2024	BUY	$7.63 - $12.66 $146,618 - $243,274	19,216 Added 41.45%	65,573 $583,000
Q1 2024 May 03, 2024	SELL	$8.6 - $11.9 $242,382 - $335,389	-28,184 Reduced 37.81%	46,357 $469,000
Q4 2023 Feb 05, 2024	SELL	$7.76 - $10.29 $376,274 - $498,951	-48,489 Reduced 39.41%	74,541 $749,000
Q3 2023 Nov 06, 2023	BUY	$9.14 - $24.62 $172,581 - $464,874	18,882 Added 18.13%	123,030 $1.15 Million
Q2 2023 Jul 27, 2023	BUY	$23.2 - $27.29 $157,040 - $184,726	6,769 Added 6.95%	104,148 $2.55 Million
Q1 2023 May 02, 2023	BUY	$22.26 - $30.85 $483,843 - $670,555	21,736 Added 28.73%	97,379 $2.27 Million
Q4 2022 Feb 10, 2023	BUY	$19.96 - $28.22 $1,576 - $2,229	79 Added 0.1%	75,643 $1.91 Million
Q4 2022 Feb 09, 2023	BUY	$19.96 - $28.22 $1.17 Million - $1.66 Million	58,773 Added 350.03%	75,564 $1.91 Million
Q3 2022 Nov 02, 2022	SELL	$18.26 - $31.1 $47,129 - $80,269	-2,581 Reduced 13.32%	16,791 $324,000
Q2 2022 Aug 01, 2022	SELL	$19.08 - $26.7 $22,380 - $31,319	-1,173 Reduced 5.71%	19,372 $493,000
Q1 2022 May 04, 2022	BUY	$21.19 - $40.01 $213,446 - $403,020	10,073 Added 96.19%	20,545 $418,000
Q4 2021 Feb 07, 2022	BUY	$30.97 - $54.03 $8,795 - $15,344	284 Added 2.79%	10,472 $438,000
Q3 2021 Nov 02, 2021	BUY	$34.9 - $54.54 $48,057 - $75,101	1,377 Added 15.63%	10,188 $443,000
Q2 2021 Aug 03, 2021	BUY	$38.75 - $51.0 $11,470 - $15,096	296 Added 3.48%	8,811 $417,000
Q1 2021 May 04, 2021	SELL	$26.34 - $83.07 $553 - $1,744	-21 Reduced 0.25%	8,515 $437,000
Q4 2020 Feb 01, 2021	SELL	$25.51 - $43.38 $34,744 - $59,083	-1,362 Reduced 13.76%	8,536 $229,000
Q3 2020 Nov 09, 2020	BUY	$28.28 - $53.6 $27,629 - $52,367	977 Added 10.95%	9,898 $340,000
Q2 2020 Aug 07, 2020	BUY	$27.89 - $47.86 $52,739 - $90,503	1,891 Added 26.9%	8,921 $365,000
Q1 2020 May 04, 2020	SELL	$12.04 - $60.2 $6,585 - $32,929	-547 Reduced 7.22%	7,030 $241,000
Q4 2019 Feb 04, 2020	BUY	$11.83 - $15.85 $89,635 - $120,095	7,577 New	7,577 $202,000

Others Institutions Holding VIR

# of Institutions

220

Shares Held

87.6M

Call Options Held

127K

Put Options Held

1.19M

View Full List

About Vir Biotechnology, Inc.

Ticker VIR
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 132,638,000
Market Cap $1.15B
Description
Vir Biotechnology, Inc., a commercial-stage immunology company, develops therapeutic products to treat and prevent serious infectious diseases. It develops Sotrovimab (VIR-7832), a SARS-CoV-2-neutralizing mAbs to treat and prevent COVID-19 infection under the Xevudy brand; VIR-2218 and VIR-3434 for the treatment of hepatitis B virus; VIR-2482 fo...

More about VIR

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Victory Capital Management Inc, based on Form 13F filings with the SEC.

News

Stay updated on Victory Capital Management Inc with notifications on news.

Account

Victory Capital Management Inc Vir Biotechnology, Inc. Transaction History